11.2 Capital
San Francisco, CA 00000
United States

Open map

Recent investment activity

KANDO id: 581876

Corporate information

Registration country


11.2 Capital is an early stage venture capital fund based in San Francisco, investing in breakthrough technology in artificial intelligence, AR/VR, robotics, space, and data-driven health. 11.2 Capital is an investor in Bay Labs, Auransa, Deep Genomics, Loop Genomics, Genturi, Molecular Assemblies, Notable Labs, Diassess, Hinge Health, and Ginkgo Bioworks.

Funding rounds

Top investment portfolio themes

Actual initial investment stage
Seed (4)
N/A (2)
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 16 of 16
Profile Country Date Funding
Anyscale Distributed computing made simple by enabling developers to easily build applications that run at any scale, from a laptop to a data center. Series A Initial investment
CryptoNumerics Inc CryptoNumerics helps organizations to use data to gain insights while overcoming privacy and data residency issues. Seed led the round
Deep Genomics Inc Seed
Elucidate GmbH Seed Initial investment led the round
Hinge Health Inc Series C Follow-on investment
Hinge Health Inc Series A Follow-on investment
Hinge Health Inc Seed Initial investment led the round
Kindred Systems Inc Developer of machines with human-like intelligence. Series A
Mantle Venture Initial investment
Notable Labs Inc N/A Initial investment
Orbital Sidekick Series A Initial investment
Outlier AI Inc Series B Follow-on investment
Outlier AI Inc Series A Initial investment
SardineAI Corp (Sardine AI) Seed Initial investment
TigerGraph TigerGraph has built the world's first, and fastest, real-time graph database and analytics platform. Seed Initial investment
Umedeor Ltd N/A Initial investment

Past employees

Selected Products / Customers